Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack requires monitoring: 0 interaction(s) need attention. No critical conflicts, but bloodwork and regular check-ins recommended.

Cumulative Organ Load

Heart
moderate
Gonads
moderate
Liver
low
Pancreas
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Pitavastatin, Testosterone). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds disrupt lipids (Pitavastatin, Testosterone). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Pitavastatin, Testosterone). Monitor accordingly.
+
Pitavastatin + Testosterone
Compatible

No interaction concerns. Supraphysiological testosterone modestly worsens lipid profiles, and pitavastatin helps maintain healthier lipid levels during testosterone cycles or TRT. Pitavastatin does not affect testosterone metabolism, aromatization, or anabolic activity. The lack of CYP3A4 involvement is a specific advantage here, as testosterone and many of its esters undergo hepatic metabolism through CYP pathways.

Researched 90% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.